Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:539

Narhex Life Sciences Limited (NLS) - Financial and Strategic SWOT Analysis Review

Narhex Life Sciences Limited (NLS) - Financial and Strategic SWOT Analysis Review

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $125.00
Meta Description Narhex Life Sciences Limited (NLS) is a biotechnology company. The company undertakes research and development of treatments for the life threatening infectious diseases, HIV. The company focuses on the development of anti-HIV protease inhibitor DG17. DG1
Publisher GlobalData
Date of Report Dec 3, 2013
Quick Overview
Summary

Narhex Life Sciences Limited (NLS) is a biotechnology company. The company undertakes research and development of treatments for the life threatening infectious diseases, HIV. The company focuses on the development of anti-HIV protease inhibitor DG17. DG17 is the water-soluble prodrug of the active anti-HIV drug DG35. NLS targets to develop DG17 for regulatory approval in OECD countries such as European Union, USA, Canada, Japan and Australia/New Zealand. It also plans to sell its products in developing markets like China and has established a joint venture with the Chinese companies interested in co-development of DG17 for the Chinese market.

This comprehensive SWOT profile of Narhex Life Sciences Limited provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Section 1 - About the Company 4
Narhex Life Sciences Limited - Key Facts 4
Narhex Life Sciences Limited - Key Employees 5
Narhex Life Sciences Limited - Key Employee Biographies 6
Narhex Life Sciences Limited - Major Products and Services 7
Narhex Life Sciences Limited - Pharmaceutical Pipeline Products Data 8
Narhex Life Sciences Limited, Pipeline Products by Therapy Area 8
Narhex Life Sciences Limited, Pipeline Products by Development Phase 9
Narhex Life Sciences Limited - History 11
Narhex Life Sciences Limited - Company Statement 12
Narhex Life Sciences Limited - Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Narhex Life Sciences Limited - Business Description 15
Narhex Life Sciences Limited - SWOT Analysis 16
SWOT Analysis - Overview 16
Narhex Life Sciences Limited - Strengths 16
Strength - Lead Product Candidate 16
Strength - Strategic Initiatives 16
Narhex Life Sciences Limited - Weaknesses 16
Weakness - History of Losses 16
Weakness - Lack of Commercial Products 16
Narhex Life Sciences Limited - Opportunities 17
Opportunity - Growth in Emerging Markets 17
Opportunity - New Joint Venture 17
Narhex Life Sciences Limited - Threats 17
Threat - Uncertain R&D Outcomes 17
Threat - Competitive Landscape 17
Threat - Stringent Government Regulations 17
Narhex Life Sciences Limited - Key Competitors 19
Section 3 – Company Financial Ratios 20
Financial Ratios - Capital Market Ratios 20
Financial Ratios - Annual Ratios 20
Performance Chart 22
Financial Performance 22
Financial Ratios - Interim Ratios 23
Financial Ratios - Ratio Charts 24
Section 4 – Company’s Lifesciences Financial Deals and Alliances 25
Narhex Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 25
Narhex Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 26
Narhex Life Sciences Limited, Recent Deals Summary 27
Section 5 – Appendix 28
Methodology 28
Ratio Definitions 28
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Narhex Life Sciences Limited, Key Facts 4
Narhex Life Sciences Limited, Key Employees 5
Narhex Life Sciences Limited, Key Employee Biographies 6
Narhex Life Sciences Limited, Major Products and Services 7
Narhex Life Sciences Limited, Number of Pipeline Products by Therapy Area 8
Narhex Life Sciences Limited, Number of Pipeline Products by Development Stage 9
Narhex Life Sciences Limited, Pipeline Products By Therapy Area and Development Phase 10
Narhex Life Sciences Limited, History 11
Narhex Life Sciences Limited, Subsidiaries 14
Narhex Life Sciences Limited, Key Competitors 19
Narhex Life Sciences Limited, Ratios based on current share price 20
Narhex Life Sciences Limited, Annual Ratios 20
Narhex Life Sciences Limited, Interim Ratios 23
Narhex Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 25
Narhex Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 26
Narhex Life Sciences Limited, Recent Deals Summary 27
Currency Codes 28
Capital Market Ratios 28
Equity Ratios 29
Profitability Ratios 29
Cost Ratios 30
Liquidity Ratios 30
Leverage Ratios 31
Efficiency Ratios 31

List of Figures
Narhex Life Sciences Limited, Pipeline Products by Therapy Area 8
Narhex Life Sciences Limited, Pipeline Products by Development Phase 9
Narhex Life Sciences Limited, Performance Chart (2008 - 2012) 22
Narhex Life Sciences Limited, Ratio Charts 24
Narhex Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 25
Narhex Life Sciences Limited, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 26




...